In an article published in the Chinese Journal of Infection
Diseases, the Shanghai Medical Association endorsed the use of high dose
vitamin C as a treatment for hospitalized people with COVID-19 (
10
).
Doses that are magnitudes higher than the DV are recommended to
be given through IV to improve lung function, which may help keep a patient off
of mechanical ventilation or life support (
10
,
11
Trusted Source
,
12
Trusted Source
).
Additionally, a 2019 review found that both oral and IV high
dose vitamin C treatment may aid people admitted to intensive care units (ICUs)
for critical illnesses by reducing ICU stay length by 8% and shortening the
duration of mechanical ventilation by 18.2% (
13
Trusted Source
).
Chinese researchers have also registered a clinical trial to
further study the effectiveness of IV vitamin C in hospitalized people with
COVID-19 (
14
).
12.
Ann Intensive Care
. 2018; 8: 3.
Published
online 2018 Jan 10.
doi:
10.1186/s13613-017-0350-x
PMCID:
PMC5768582
PMID:
29330690
Compared
to the control group, the ECMO group had significantly lower in-hospital
mortality (65 vs. 100%;
P
= 0.02),
longer ICU stay (25 vs. 8 days;
P
= 0.001)
(Table
5
and Fig.
1
). Less use of norepinephrine at days 1 and
14 (
P
< 0.05), and better oxygenation (higher PaO
2
/FiO
2
ratio) throughout days 7–14 (Table
2
).
Nutrients
. 2019 Apr; 11(4): 708.
Published
online 2019 Mar 27.
doi:
10.3390/nu11040708
PMCID:
PMC6521194
PMID:
30934660
Harri Hemilä
1,*
and
Elizabeth Chalker
2
A number of
controlled trials have previously found that in some contexts, vitamin C can
have beneficial effects on blood pressure, infections, bronchoconstriction,
atrial fibrillation, and acute kidney injury. However, the practical
significance of these effects is not clear. The purpose of this meta-analysis
was to evaluate whether vitamin C has an effect on the practical outcomes:
length of stay in the intensive care unit (ICU) and duration of mechanical
ventilation. We identified 18 relevant controlled trials with a total of 2004
patients, 13 of which investigated patients undergoing elective cardiac
surgery. We carried out the meta-analysis using the inverse variance, fixed
effect options, using the ratio of means scale. In 12 trials with 1766
patients, vitamin C reduced the length of ICU stay on average by 7.8% (95% CI:
4.2% to 11.2%;
p
= 0.00003). In six trials, orally
administered vitamin C in doses of 1–3 g/day (weighted mean 2.0 g/day) reduced
the length of ICU stay by 8.6% (
p
= 0.003). In three trials in which
patients needed mechanical ventilation for over 24 hours, vitamin C shortened
the duration of mechanical ventilation by 18.2% (95% CI 7.7% to 27%;
p
=
0.001).
https://www.mdpi.com/2072-6643/11/4/708
N Y Hospital uses vitamin C effectively
in treating Coronavirus-
https://www.nutraingredients.com/Article/2020/03/25/Hospital-turns-to-high-dose-vitamin-C-to-fight-coronavirus
(patients who received vitamin C did
significantly better)
The Shanghai Medical Association
& Gov’t has endorsed High Dose Vit C IV for treatment of CV- https://mp.weixin.qq.com/s/bF2YhJKiOfe1yimBc4XwOA
Dr. Cheng states that the principle investigator of the first
high-dose IV vitamin C trial in China has told him that the preliminary results
of the study are promising. The investigator said the administration of 24
grams per day to COVID-19 patients leads to significant reductions in
inflammation. Dr. Cheng said this is notable because massive inflammation in
the lungs and potentially other organs may be fatal in the illness.
https://www.medicinenet.com/coronavirus_covid-19_sars_cov_2_news_updates/article.htm
IV Vit C was effective in use for ARDS-
World J Crit Care Med
. 2017 Feb 4; 6(1): 85–90.
Published
online 2017 Feb 4.
doi:
10.5492/wjccm.v6.i1.85
PMCID:
PMC5295174
PMID:
28224112
Alpha A Fowler III
,
et al,
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5295174/
Infusing high dose intravenous
vitamin C
into this
patient with virus-induced
ARDS
was associated with rapid resolution of lung injury with no
evidence of post-
ARDS
fibroproliferative
sequelae. Intravenous
vitamin C
as a treatment for
ARDS
may open a
new era of therapy for
ARDS
from many causes.
Nutrients.
2020 Apr
2;12(4). pii: E988. doi: 10.3390/nu12040988.
Grant WB
1
et
al -
https://www.ncbi.nlm.nih.gov/pubmed/32252338
Rev Esp Anestesiol Reanim.
2020 Apr
14. pii: S0034-9356(20)30075-X. doi: 10.1016/j.redar.2020.03.004. [Epub ahead
of print]
[
Article
in English, Spanish]
(Vitamin C IV & Ozone),
Hernández A
1
et al
https://www.ncbi.nlm.nih.gov/pubmed/32303365
J Antimicrob Chemother
. 2003 Dec; 52(6): 1049–1050.
Published
online 2003 Dec.
doi:
10.1093/jac/dkh002
PMCID:
PMC7110025
,
PMID:
14613951
Harri Hemilä
- https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7110025/
vitamin C
increased the resistance of chick embryo tracheal organ cultures to infection
caused by an avian coronavirus.
4
Studies
in animals found that vitamin C modifies susceptibility to various bacterial
and viral infections,
3
for
example protecting broiler chicks against an avian coronavirus.
5
Placebo-controlled
trials have shown quite consistently that the duration and severity of common
cold episodes are reduced in the vitamin C groups,
3
indicating
that viral respiratory infections in humans are affected by vitamin C levels.
There is also evidence indicating that vitamin C may affect pneumonia.
3
In
particular, three controlled trials with human subjects reported a
significantly lower incidence of pneumonia in vitamin C-supplemented groups,
6
suggesting
that vitamin C may affect susceptibility to lower respiratory tract infections
under certain conditions.
Hemilä, H. & Douglas, R. M. (1999). Vitamin C and acute
respiratory infections. International Journal of Tuberculosis and Lung
Diseases 3, 756–61. [
PubMed
]
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue.
2020 Jan;32(1):1-7. doi:
10.3760/cma.j.cn121430-20191213-00001.
[Article in Chinese]
Huang W
1
,
Qin Y
,
Dai X
.
-
https://www.ncbi.nlm.nih.gov/pubmed/32148223
many significantly important trials with positive
results: high dose
vitamin C
for septic shock,
Inflammation.
2019 Oct;42(5):1585-1594. doi:
10.1007/s10753-019-01020-2.
Erol N
1
,
-
https://www.ncbi.nlm.nih.gov/pubmed/31081527
ALA, VITE, VITC, and both dose of MP
significantly decreased the cytokine levels.
Surg Infect (Larchmt).
2018
Nov/Dec;19(8):812-820. doi: 10.1089/sur.2018.111. Epub 2018 Jul 24.
Marik PE
1
.
- https://www.ncbi.nlm.nih.gov/pubmed/30040533
BMJ Case Rep.
2018 Feb
2;2018. pii: bcr-2017-223475. doi: 10.1136/bcr-2017-223475.
Marik PE
1
,
Long A
1
.
https://www.ncbi.nlm.nih.gov/pubmed/29420246-
patient made a dramatic recovery being
weaned to nasal cannulae within 24 hours after the initiation of this treatment
protocol and was discharged home a few days later.
Ann Surg.
2002
Dec;236(6):814-22.
Nathens AB
1
,
et al--
https://www.ncbi.nlm.nih.gov/pubmed/12454520
The early administration of antioxidant
supplementation using alpha-tocopherol and ascorbic acidreduces the
incidence of organ failure and shortens ICU length of stay in this cohort of
critically ill surgical patients.
Int J Mol Sci.
2020 Feb 1;21(3). pii: E977. doi:
10.3390/ijms21030977.
Patel V
1.
https://www.ncbi.nlm.nih.gov/pubmed/32024151
dietary antioxidants,
ascorbic acid
and sulforaphane, ameliorate HALI and attenuate hyperoxia-induced
macrophage dysfunction through an HMGB1-mediated pathway.
Sepsis
J Thorac Dis.
2020
Feb;12(Suppl 1):S84-S88. doi: 10.21037/jtd.2019.12.64.
Marik PE
1
.
-
https://www.ncbi.nlm.nih.gov/pubmed/32148930
reatment with
vitamin C
appears to restore the stress response and improve the
survival of stressed humans.
J Intensive Care.
2020 Feb
7;8:15. doi: 10.1186/s40560-020-0432-y. eCollection 2020.
Hemilä H
1
,
Chalker E
2
.
https://www.ncbi.nlm.nih.gov/pubmed/32047636
We found strong evidence that
vitamin C
shortens the duration of mechanical ventilation,
J Trauma Acute Care Surg.
2020 Feb 7.
doi: 10.1097/TA.0000000000002613. [Epub ahead of print]
Byerly S
-
https://www.ncbi.nlm.nih.gov/pubmed/32039973
VitC+THMN is associated with increased survival
in septic ICU patients
NAC.
Hum Exp Toxicol.
2007 Sep;26(9):697-703.
Soltan-Sharifi MS
1.
https://www.ncbi.nlm.nih.gov/pubmed/17984140
patients with
ARDS
are in a deficient oxidant-anti-oxidant balance
that can get a significant benefit if supplemented with NAC.
January 1994
Volume 105, Issue 1,
Pages 190–194
Peter M. Suter,
et al; https://journal.chestnet.org/article/S0012-3692(15)43843-7/abstract
Vit D
Biochem Pharmacol.
2020 Apr
3:113955. doi: 10.1016/j.bcp.2020.113955. [Epub ahead of print]
Zheng S
1
,
Nutrients.
2020 Apr
2;12(4). pii: E988. doi: 10.3390/nu12040988.
Grant WB
1
,
et al; https://www.ncbi.nlm.nih.gov/pubmed/32252338
BMJ Open Respir Res.
2015 Jun
13;2(1):e000074. doi: 10.1136/bmjresp-2014-000074. eCollection 2015.
Compared to patients with 25(OH)D ≥30 ng/mL,
patients with lower 25(OH)D levels had significantly higher adjusted odds of
acute respiratory failure
Inflamm Allergy Drug Targets.
2013 Aug;12(4):253-61.
Parekh D
1
-
https://www.ncbi.nlm.nih.gov/pubmed/23782208
The evidence for
the role of vitamin D in lung disease is growing - deficiency has been
associated with impaired pulmonary function, increased incidence of viral and
bacterial infections and inflammatory disease including asthma and COPD.
Studies have also reported a high prevalence of vitamin D deficiency in the
critically ill and an association with adverse outcomes.